A detailed history of Trillium Asset Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Trillium Asset Management, LLC holds 18,084 shares of VRTX stock, worth $7.33 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
18,084
Previous 17,579 2.87%
Holding current value
$7.33 Million
Previous $8.24 Million 2.08%
% of portfolio
0.21%
Previous 0.21%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$460.0 - $505.78 $232,300 - $255,418
505 Added 2.87%
18,084 $8.41 Million
Q2 2024

Aug 07, 2024

BUY
$392.81 - $485.53 $6.91 Million - $8.54 Million
17,579 New
17,579 $8.24 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $104B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Trillium Asset Management, LLC Portfolio

Follow Trillium Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trillium Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trillium Asset Management, LLC with notifications on news.